--Sanofi SA is looking at potential U.S. biotech acquisitions as it seeks to expand its work in multiple sclerosis and immune disorders, Bloomberg reports, citing unnamed sources.

--One of the targets being studied by the French company is Pricipia Biopharma Inc., Bloomberg reports.

Full story: https://bloom.bg/2CF0OYj

Write to Barcelona editors at barcelonaeditors@dowjones.com

(END) Dow Jones Newswires

July 17, 2020 02:14 ET (06:14 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Grafico Azioni Principia Biopharma (NASDAQ:PRNB)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Principia Biopharma
Grafico Azioni Principia Biopharma (NASDAQ:PRNB)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Principia Biopharma